79 related articles for article (PubMed ID: 20665664)
1. Hepatic expression profiling shows involvement of PKC epsilon, DGK eta, Tnfaip, and Rho kinase in type 2 diabetic nephropathy rats.
Gupta J; Gaikwad AB; Tikoo K
J Cell Biochem; 2010 Nov; 111(4):944-54. PubMed ID: 20665664
[TBL] [Abstract][Full Text] [Related]
2. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
[TBL] [Abstract][Full Text] [Related]
3. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
[TBL] [Abstract][Full Text] [Related]
4. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
[TBL] [Abstract][Full Text] [Related]
5. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
6. Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53.
Tikoo K; Tripathi DN; Kabra DG; Sharma V; Gaikwad AB
FEBS Lett; 2007 Mar; 581(5):1071-8. PubMed ID: 17316625
[TBL] [Abstract][Full Text] [Related]
7. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
Wang Y; Ng MC; So WY; Ma R; Ko GT; Tong PC; Chan JC
Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy.
Takahashi H; Takeishi Y; Seidler T; Arimoto T; Akiyama H; Hozumi Y; Koyama Y; Shishido T; Tsunoda Y; Niizeki T; Nozaki N; Abe J; Hasenfuss G; Goto K; Kubota I
Circulation; 2005 Mar; 111(12):1510-6. PubMed ID: 15781737
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J
Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379
[TBL] [Abstract][Full Text] [Related]
10. Glucose-dependent enhancement of diabetic bladder contraction is associated with a rho kinase-regulated protein kinase C pathway.
Nobe K; Yamazaki T; Tsumita N; Hashimoto T; Honda K
J Pharmacol Exp Ther; 2009 Mar; 328(3):940-50. PubMed ID: 19050171
[TBL] [Abstract][Full Text] [Related]
11. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
12. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
13. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy.
Sugano M; Yamato H; Hayashi T; Ochiai H; Kakuchi J; Goto S; Nishijima F; Iino N; Kazama JJ; Takeuchi T; Mokuda O; Ishikawa T; Okazaki R
Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):477-84. PubMed ID: 17015185
[TBL] [Abstract][Full Text] [Related]
14. Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: effects on gene expression in insulin-sensitive tissues determined by high-density oligonucleotide microarray analysis.
Colombo M; Gregersen S; Kruhoeffer M; Agger A; Xiao J; Jeppesen PB; Orntoft T; Ploug T; Galbo H; Hermansen K
Metabolism; 2005 Dec; 54(12):1571-81. PubMed ID: 16311088
[TBL] [Abstract][Full Text] [Related]
15. Identification of variations of gene expression of visceral adipose and renal tissue in type 2 diabetic rats using cDNA representational difference analysis.
Yang J; Li G; Zhang F; Liu Y; Zhang D; Zhou W; Xu G; Yang Y; Luo M
Chin Med J (Engl); 2003 Apr; 116(4):529-33. PubMed ID: 12875716
[TBL] [Abstract][Full Text] [Related]
16. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
18. Increase in DPP-IV in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin.
Yang J; Campitelli J; Hu G; Lin Y; Luo J; Xue C
Life Sci; 2007 Jul; 81(4):272-9. PubMed ID: 17583752
[TBL] [Abstract][Full Text] [Related]
19. Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats.
Bi Y; Sun WP; Chen X; Li M; Liang H; Cai MY; Zhu YH; He XY; Xu F; Weng JP
Acta Diabetol; 2008 Sep; 45(3):167-78. PubMed ID: 18500427
[TBL] [Abstract][Full Text] [Related]
20. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M
Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
